LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX),a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its fourth quarter and full-year 2010 financial results and an operational update in a press release to be issued before the market opens on Tuesday, March 29, 2011.
